Probiotics reduce severe eczema symptoms for infants under three: Meta-analysis

By Gary Scattergood contact

- Last updated on GMT

The study also found that disease severity was associated with the effect of probiotic treatment. ©Getty Images
The study also found that disease severity was associated with the effect of probiotic treatment. ©Getty Images

Related tags: Gut flora

Probiotics have been found to have a significant impact on the management of eczema in infants under the age of three, according to what is believed to be the first meta-analysis on the topic.

A recent review showed that the administration of mixed strains of bacteria is beneficial to the treatment of eczema​. However, evidence of its efficacy is less conclusive in infants.

Therefore researchers in China assessed the outcomes of seven studies, which examined 609 children aged under three years.

Writing in the International Journal of Dermatology​, they stated: “To the best of our knowledge, this is the first meta-analysis focusing on the treatment effect of probiotics in infants. In the current meta-analysis, we found a significant effect of probiotics in the management of infantile [eczma].

Subgroup analysis found that Lactobacillus​ strains appeared to be particularly protective in the treatment of the condition.

However, only three studies, involvingaccruing 148 subjects for the treatment and the control group combined, investigated the effect of Bifidobacterium​ species.

“As such, results of Bifidobacterium should be viewed with caution due to the smaller size and heterogeneity of studies. It might be fruitful to further explore the effect of bifidobacteria in combination with Lactobacillus or alone in larger trials,”​ they added.

Severity and age key

The study also found that disease severity was associated with the effect of probiotic treatment, with the more severe the condition, the greater the impact.

“In infants with moderate-to-severe diseases, we observed a significantly protective effect, whereas in participants with milder diseases, the effect was not significant, which was in accordance with previous meta-analysis where older children were studied,”​ they noted.

Another key finding was that probiotic treatment might be more effective in infants aged less than 12 months.

“One possible explanation is that children of one year of age or less are less subjective to other dietary supplements, which at older ages might become allergens and contribute to exacerbation,”​ wrote the researchers.

They added that more research was required to assess safety profile of probiotic treatment, arguing that incidents of common side effects, including constipation, nausea, infection, and rash, were infrequently registered in studies.

Nevertheless, they concluded: “The current analysis favors the employment of probiotics in children. However, caution should be raised when treating children less than one year of age. Moreover, mild subjects constitute exceptions of this beneficial effect.

“More studies investigating efficacy of Bifidobacterium strains could be informative. Also, further larger studies are needed to address the safety, dose-response profile, and long-term effect of probiotics in the treatment of paediatric [eczema].”

The relationship between infant gut microbiota and allergies is a growing area of interst for researchers. One recent study,​ backed by Danone, found "pronounced differences in intestinal microbiota composition between allergic and healthy infants"​ at three months of age.

Source: International Journal of Dermatology

https://doi.org/10.1111/ijd.13873

"Treatment efficacy of probiotics on atopic dermatitis, zooming in on infants: a systematic review and meta-analysis"

Authors: Mutong Zhao M, et al.

Related news

Show more

Related products

show more

Proteins for dry blending

Proteins for dry blending

Arla Foods Ingredients Group P/S | 24-Feb-2021 | Technical / White Paper

Arla Foods Ingredients has launched a new dry-blend protein ingredient which helps infant formula manufacturers reduce production costs while guaranteeing...

Covid-19: A Game Changer for Probiotics

Covid-19: A Game Changer for Probiotics

Lumina Intelligence | 09-Feb-2021 | Technical / White Paper

This free whitepaper from Lumina Intelligence examines how the pandemic has impacted post-purchase consumer engagement with probiotics, the role of probiotics...

HRB probiotics: The gift of life for infant health

HRB probiotics: The gift of life for infant health

Morinaga Milk Industry Co., Ltd. | 29-Jun-2020 | Technical / White Paper

Bifidobacteria are among the first colonizers of human gut, and certain species are recognised as Human-Residential Bifidobacteria (HRB) - the natural...

Related suppliers

Follow us

Products

View more

Webinars

Nutra Champions Podcast

Nutra Champions Podcast